Blogs

USP <232> and <233> effective as of January 1st, 2018. Is your company in compliance?

2018-05-10T07:13:25+00:00

Quality Assurance Units must provide assurance that the validation process has produced the expected results as per the requirements of USP General Chapter <233> Elemental Impurities in accordance with <1225> Validation of compendial procedures

USP <232> and <233> effective as of January 1st, 2018. Is your company in compliance? 2018-05-10T07:13:25+00:00

Whitehouse Laboratories To Participate On The Medical Device Reprocessing Panel Discussion At MD&M East

2018-05-10T07:13:26+00:00

MD&M East Schedule Whitehouse Laboratories is excited to announce that it has accepted an invitation to participate on the [...]

Whitehouse Laboratories To Participate On The Medical Device Reprocessing Panel Discussion At MD&M East 2018-05-10T07:13:26+00:00

What the Ever-Changing Revisions to USP <661> Really Mean & How the Industry is Responding

2018-05-10T07:13:26+00:00

John Iannone, Director, Extractables & Leachables (John.Iannone@amriglobal.com) Brandon Zurawlow, Associate Director, Container Qualification & CCIT (Brandon.Zurawlow@amriglobal.com) May, 2017 Recently, USP [...]

What the Ever-Changing Revisions to USP <661> Really Mean & How the Industry is Responding 2018-05-10T07:13:26+00:00

Proposed Revisions to ISO 11607 – The Potential Impact on Medical Device Performance Testing

2018-05-10T07:13:26+00:00

Highlights of Proposed Revisions to ISO 11607 Adapted from HealthPack 2017 presentation, “The Next generation of ISO 11607”, by Nick [...]

Proposed Revisions to ISO 11607 – The Potential Impact on Medical Device Performance Testing 2018-05-10T07:13:26+00:00